Back to Screener

Healthcare

KalVista Pharmaceuticals, Inc.(KALV)

Live Price

Offline

$27.00

+0.00% today

1Y Change

+131.16%

Window

Jun 25, 2025 โ†’ Jun 12, 2026

Market Cap
$1.37B
Revenue Growth
0.0%
EPS Growth
-7.3%
Dividend Yield
0.0%

Coverage: 243 bars ยท Jun 25, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

KalVista Pharmaceuticals, Inc. (KALV) is a Healthcare stock with a market cap of $1.37B and listed on NASDAQ. The stock last traded around $27.00 and up 131.2% across the available one-year price window (Jun 25, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -7.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -7.3%, free cash flow -71.0% with operating margin -231.1% and ROIC -57.9%. Valuation already assumes a fairly strong business story at price/sales 18.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines KALV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

KALV vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

KALV

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

KALV Max Drawdown

-32.79%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for KALV and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsSep 3, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Sep 3, 26
TBD
โ€”
Est -0.39
โ€”
โ€”
Est 38344.8B
โ€”
Sep 3
โ€”
May 5, 26
โ€”
Est -0.41
โ€”
โ€”
Est 38723.4B
โ€”
May 5
โ€”
Mar 24, 26
โœ—
-1.01
Est -0.54
-87.0%
1426.0B
Est 5352.0B
-73.4%
Mar 24
โ€”
Nov 10, 25
โœ“
-0.92
Est -0.96
+4.2%
13692.0B
Est 32285.7B
-57.6%
Nov 10
โ€”
Sep 11, 25
โœ—
-1.12
Est -0.91
-23.1%
1426.0B
Est 12614.2B
-88.7%
Sep 11
โ€”
Jul 10, 25
โœ—
-0.99
Est -0.77
-28.6%
โ€”
Est 4201.5B
โ€”
Jul 10
โ€”
Mar 12, 25
โœ—
-0.92
Est -0.89
-3.4%
โ€”
Est โ€”
โ€”
Mar 12
โ€”
Dec 5, 24
โ€”
-0.91
Est -0.91
0.0%
โ€”
Est โ€”
โ€”
Dec 5
โ€”
Sep 5, 24
โœ“
-0.87
Est -0.91
+4.4%
โ€”
Est โ€”
โ€”
Sep 5
โ€”
Jul 11, 24
โœ—
-1.02
Est -0.73
-39.7%
โ€”
Est โ€”
โ€”
Jul 11
โ€”
Mar 11, 24
โœ—
-0.84
Est -0.77
-9.1%
โ€”
Est โ€”
โ€”
Mar 11
โ€”
Dec 7, 23
โœ—
-0.80
Est -0.79
-1.3%
โ€”
Est โ€”
โ€”
Dec 7
โ€”
Sep 7, 23
โœ“
-0.74
Est -0.86
+13.9%
โ€”
Est โ€”
โ€”
Sep 7
โ€”
Jul 7, 23
โœ“
-0.77
Est -0.92
+16.3%
โ€”
Est โ€”
โ€”
Jul 7
โ€”
Mar 9, 23
โœ“
-0.75
Est -0.97
+22.7%
โ€”
Est โ€”
โ€”
Mar 9
โ€”
Dec 8, 22
โœ“
-0.90
Est -1.06
+15.1%
โ€”
Est โ€”
โ€”
Dec 8
โ€”
Sep 8, 22
โœ“
-0.94
Est -1.04
+9.6%
โ€”
Est โ€”
โ€”
Sep 8
โ€”
Jul 7, 22
โœ“
-0.98
Est -1.09
+10.1%
โ€”
Est โ€”
โ€”
Jul 7
โ€”
Mar 10, 22
โœ“
-0.92
Est -0.93
+1.1%
โ€”
Est โ€”
โ€”
Mar 10
โ€”
Dec 9, 21
โœ—
-0.80
Est -0.79
-1.3%
โ€”
Est โ€”
โ€”
Dec 9
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.